7SF-14969-20602
2 vaccinations
3 coded responses
26 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 524 / IA
- Registered
- 2021-09-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-09-18
Registered in v-safe
-
2021-09-18
Dose 1 — Moderna
- 2021-09-18
- 2021-09-19
- 2021-09-20
- 2021-09-21
- 2021-09-22
- 2021-09-23
- 2021-09-24
- 2021-09-25
- 2021-10-03
- 2021-10-09
-
2021-10-18
Dose 2 — Moderna
- 2021-10-18
-
2021-10-19
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
-
2021-10-20
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fatigue or tirednessFree text: Sweaty feelingMedDRA releases: 2024-11 · check-in free text available
- 2021-10-21
- 2021-10-22
- 2021-10-23
- 2021-10-24
- 2021-10-25
- 2021-11-01
- 2021-11-08
-
2021-11-15
Survey response — day 28, dose 2MedDRA: Headache, Vomiting — Feeling: FairFree text: Headache/ vomitingMedDRA releases: 2024-11 · check-in free text available
- 2021-11-24
-
2021-12-01
Survey response — day 42, dose 2MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: URI - non covidMedDRA releases: 2024-11 · check-in free text available
-
2021-12-01
Report sent to call center — day 42, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-12-02
- 2022-01-17
- 2022-04-18
- 2022-10-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-09-18 | Moderna | No |
| 2 | 2021-10-18 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-12-01 | Unsuccessful |
Free text
Release 10 — days 1–6 daily, dose 2
Systemic reaction (other): Sweaty feeling
Release 10 — day 28, dose 2
Symptoms: Headache/ vomiting
Release 10 — day 42, dose 2
Symptoms: URI - non covid
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Headache | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Hyperhidrosis | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release